SCHEMBL815068

SCHEMBL815068

CC(C)N=C=Nc1ccccc1C(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 7/20 0.39
NOS3 P29474 2/20 0.39
NOS1 P29475 2/20 0.39
NOS2 P35228 2/20 0.39
GRIN2D O15399 1/20 0.39
GRIN3B O60391 1/20 0.39
GRIN1 Q05586 1/20 0.39
GRIN2A Q12879 1/20 0.39
GRIN2B Q13224 1/20 0.39
GRIN2C Q14957 1/20 0.39
GRIN3A Q8TCU5 1/20 0.39
GABRA1 P14867 3/20 0.38
GABRB2 P47870 2/20 0.38
LMNA P02545 2/20 0.34
GABRG2 P18507 2/20 0.34
GABRB3 P28472 2/20 0.34
FAAH O00519 2/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CYP1A2 P05177 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL160103 0.88 SIGMAR1 (0.43) SIGMAR1NOS3NOS1NOS2GRIN2D
Isobutane SCHEMBL27956334 0.86 SIGMAR1 (0.42) SIGMAR1NOS3NOS1NOS2GRIN2D
Ethane SCHEMBL15090384 0.86 SIGMAR1 (0.42) SIGMAR1NOS3NOS1NOS2GRIN2D
SCHEMBL27804935 0.84 GABRA1 (0.35) SIGMAR1NOS3NOS1NOS2GRIN2D
SCHEMBL28530950 0.84 GABRA1 (0.35) SIGMAR1NOS3NOS1NOS2GRIN2D
SCHEMBL7730554 0.81 MIF (0.43) SIGMAR1NOS3NOS1NOS2GRIN2D
Butane SCHEMBL15090403 0.81 NOS3 (0.46) SIGMAR1NOS3NOS1NOS2GRIN2D
SCHEMBL25895341 0.78 TSHR (0.40) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL29135837 0.78 SIGMAR1 (0.42) SIGMAR1NOS3NOS1NOS2GRIN2D
SCHEMBL462794 0.76 CYP3A4 (0.52) SIGMAR1NOS3NOS1NOS2GRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102015889-B Method for producing polylactic acid resin composition KAO CORP 2013-02-06 CN claimed
CN-102660797-A Preparation method of hydrolysis-resistant modified polylactic acid fibers UNIV DONGHUA 2012-09-12 CN claimed
CN-102286183-A Plastic polyvinyl alcohol (PVA) resin and preparation method thereof 2011-12-21 CN claimed
CN-102015889-A Method for producing polylactic acid resin composition KAO CORP 2011-04-13 CN claimed
US-6767548-B2 STABILIZED CONCENTRATES CONTAINING MICROBIOCIDESM MIXTURE OF OIL, CARDIIMIDE COMPOUND AND EMULSIFIER ISP INVESTMENTS INC. 2004-07-27 US claimed
US-20030165554-A1 Gel inhibited liquid carrier for a biocide containing a carbodiimide and an emulsifier mixture ISP INVESTMENTS INC. 2003-09-04 US claimed
WO-2003069992-A1 GEL INHIBITED LIQUID CARRIER FOR A BIOCIDE CONTAINING A CARBODIIMIDE AND AN EMULSIFIER MIXTURE ISP INVESTMENTS INC. (US) 2003-08-28 WO claimed
US-6479438-B2 USEFUL AGROCHEMICAL SOLUTIONS AND ADDITIONALLY HAVE SEVERAL OTHER NON-AGROCHEMICAL USES INCLUDING DILUENTS FOR FORMING OIL-IN-WATER (O/W) OR WATER-IN-OIL (W/O) MICROEMULSIONS FOR CLEANING AND DISINFECTING FORMULATIONS, PESTICIDAL SPRAYS ISP INVESTMENTS INC. 2002-11-12 US claimed
US-20020128153-A1 Gel inhibited liquid carrier for a biocide containing a carbodiimide and an emulsifier mixture ISP INVESTMENTS INC. 2002-09-12 US claimed
WO-2002052938-A1 GEL INHIBITED LIQUID CARRIER FOR A BIOCIDE CONTAINING A CARBODIIMIDE AND AN EMULSIFIER MIXTURE ISP INVESTMENTS INC. (US) 2002-07-11 WO claimed
US-20260145378-A1 RESIN MIXTURE, PREFORM, BIAXIALLY ORIENTED MOLDED ARTICLE, RESIN PELLET AND METHOD FOR PRODUCING BIAXIALLY ORIENTED MOLDED ARTICLE CANON KABUSHIKI KAISHA (JP) 2026-05-28 US disclosed
EP-4427909-B1 METHOD OF PRODUCING BLOW-MOLDED PRODUCT, RESIN COMPOSITION, AND PELLETS CANON KK (JP) 2026-05-06 EP disclosed
EP-4450252-B1 METHOD OF PRODUCING STRETCH-BLOW-MOLDED ARTICLE CANON KK (JP) 2026-04-22 EP disclosed
EP-4717437-A2 POLYMER, PREFORM, BIAXIALLY STRETCHED MOLDED ARTICLE, RESIN PELLET, AND METHOD OF PRODUCING BIAXIALLY STRETCHED MOLDED ARTICLE Canon Kabushiki Kaisha (JP) 2026-04-01 EP disclosed
US-20260085185-A1 POLYMER, PREFORM, BIAXIALLY STRETCHED MOLDED ARTICLE, RESIN PELLET, AND METHOD OF PRODUCING BIAXIALLY STRETCHED MOLDED ARTICLE CANON KK (JP) 2026-03-26 US disclosed
EP-1427876-A1 STABILISED POLYESTER COMPOSITIONS AND MONOFILAMENTS THEREOF Voith Fabrics Patent GmbH (DE) 2004-06-16 EP disclosed
WO-2003010370-A1 STABILISED POLYESTER COMPOSITIONS AND MONOFILAMENTS THEREOF FOR USE IN PAPERMACHINE CLOTHING AND OTHER INDUSTRIAL FABRICS VOITH FABRICS HEIDENHEIM GMBH & CO. KG (DE) 2003-02-06 WO disclosed
US-5260375-A Blend of certain copolymer of styrene with an olefinically unsaturated monomer having at least one carboxy, anhydride, tert-butylester, hydroxy or amino group BASF AKTIENGESELLSCHAFT (DE) 1993-11-09 US disclosed
US-5237000-A Graft rubber based on butadiene; fiber of particulate filler BASF AKTIENGESELLSCHAFT (DE) 1993-08-17 US disclosed
US-5216062-A Blended with graft addition polymers; acrylates, styrene, acrylonitrile and butadiene BASF AKTIENGESELLSCHAFT (DE) 1993-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260145378-A1 RESIN MIXTURE, PREFORM, BIAXIALLY ORIENTED MOLDED ARTICLE, RESIN PELLET AND METHOD FOR PRODUCING BIAXIALLY ORIENTED MOLDED ARTICLE RICTOR, MAP1LC3B, BZW1 SIGMAR1 886/4885NOS3 1280/4885NOS1 1490/4885
US-20260085185-A1 POLYMER, PREFORM, BIAXIALLY STRETCHED MOLDED ARTICLE, RESIN PELLET, AND METHOD OF PRODUCING BIAXIALLY STRETCHED MOLDED ARTICLE PCNA, MFAP1, FFAR1 SIGMAR1 563/4885NOS3 2593/4885NOS1 2153/4885
US-20030165554-A1 Gel inhibited liquid carrier for a biocide containing a carbodiimide and an emulsifier mixture HAO2, HAAO, ALOX12 SIGMAR1 1421/4885NOS3 1004/4885NOS1 1272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.